In this first-in-human pilot trial, Norton, Papaefthymiou, Telese, Vignolo, Rodriguez Grunert, and Haidry explored radiofrequency vapor ablation (RFVA) as a…
Browsing: Clinical Updates
A recent review in Clinical Advances in Hematology & Oncology spotlights promising developments in gastrointestinal oncology — especially for colorectal…
Dr. Robin Mendelsohn, Co-Director of MSK’s Center for Young Onset Colorectal and GI Cancers, weighs in on the FDA-approved Shield…
The American Gastroenterological Association reports that CMS’s 2026 payment proposal could deliver a windfall to GI practices performing endoscopy in-office…
Jennifer Byrne reports — with fact-checking by Heather Biele — that a study led by Jared A. Sninsky, MD, MSCR…
A new review by Pooja N. Dave and Sarah Kinsinger explores advances in brain-gut behavior therapies (BGBTs) for disorders of…
Anbogen Therapeutics has received FDA clearance to launch a phase 1/2 trial of ABT-301, a selective HDAC1/2/3 inhibitor, in combination…
MARLBOROUGH, Mass., Aug. 6, 2025 – Boston Scientific Corporation (NYSE: BSX) today announced data from a recent national survey of…
AGA’s new web portal helps you navigate payor-imposed challenges that interfere with timely, evidence-based IBD care. IBD physicians and APPs,…
In a recent commentary, Dr. David Johnson highlights two accessible interventions—exercise and aspirin—that could significantly lower colorectal cancer recurrence risk.…